Is there a role for maraviroc to treat HIV-associated central nervous system white matter disease?

AIDS. 2016 Jan;30(2):334-6. doi: 10.1097/QAD.0000000000000954.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Cyclohexanes / therapeutic use*
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Leukoencephalopathies / drug therapy*
  • Leukoencephalopathies / pathology
  • Male
  • Maraviroc
  • Treatment Outcome
  • Triazoles / therapeutic use*

Substances

  • Anti-HIV Agents
  • Cyclohexanes
  • Triazoles
  • Maraviroc